Earlier studies showed that inhibitors of mTOR increase Mirk kinase expression, and the combination of a Mirk kinase inhibitor and the mTOR inhibitor RAD001 killed more SKOV3 and TOV21G ovarian cancer cells than either agent alone (23). This evidence concerns the gene MTOR and ovarian cancer.